Clinical Neurology and Neurosurgery
Volume 112, Issue 6 , Pages 459-462, July 2010

Comparative analysis of cerebrospinal fluid adenosine deaminase in tuberculous and non-tuberculous meningitis

  • Ali Moghtaderi

      Affiliations

    • Department of Neurology, Zahedan University of Medical Sciences, Zahedan, Iran
    • Corresponding Author InformationCorresponding author at: Neurology Department, Imam-Ali Teaching Hospital, Zahedan 9815733169, Iran. Tel.: +98 541 3218016; fax: +98 541 3218848.
  • ,
  • Abbasali Niazi

      Affiliations

    • Department of Pathology, Zahedan University of Medical Sciences, Zahedan, Iran
  • ,
  • Roya Alavi-Naini

      Affiliations

    • Department of Infectious Diseases, Research Center for Tropical and Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran
  • ,
  • Saideh Yaghoobi

      Affiliations

    • Zahedan University of Medical Sciences, Clinical Research Development Center, Zahedan, Iran
  • ,
  • Behzad Narouie

      Affiliations

    • Zahedan University of Medical Sciences, Clinical Research Development Center, Zahedan, Iran

Received 17 December 2008; received in revised form 7 December 2009; accepted 10 December 2009.

Abstract 

Objective

To calculate cut-off point for the adenosine deaminase (ADA) activity in the CSF of patients with tuberculous meningitis (TBM).

Patients and methods

The ADA assay was based on the automatic indirect method in which ADA catalyzes adenosine to inosine. ADA activity in the CSF was calculated based on ammonia liberated from adenosine and quantified spectrophotometrically. Arithmetic mean values and standard deviation of each variable were measured. Mann–Whitney U and Fisher exact tests were applied to compare continuous and dichotomous variables between tuberculous and non-tuberculous groups. A receiver operating characteristic curve was plotted to identify various cut-off points to determine the best level for ADA activity.

Results

Totally 42 patients were enrolled into the study. The median of ADA activity in the TBM group was 22 and in the non-TBM group was 8.0. The mean CSF-ADA activity was found to be significantly higher in TBM group (23.05±13.1IU/L) than in the CSF from non-TBM patients (9.39±5.18IU/L). The highest accuracy is at the cut-off value of 10.5IU/L. The sensitivity and specificity of the test at this cut-off to differentiate TBM from non-tuberculous meningitis is 81% and 86% respectively.

Conclusion

Considering that a high positive value of ADA activity cannot confirm TBM, however, in suspected patients it may lead the physician to treat patient earlier before the confirmatory diagnostic reports will be received. The suggested cut-off value in this pilot study is 10.5IU/L with high sensitivity and specificity.

Keywords: Tuberculosis, Adenosine deaminase, Tuberculous meningitis, Bacterial meningitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0303-8467(09)00339-4

doi:10.1016/j.clineuro.2009.12.006

Clinical Neurology and Neurosurgery
Volume 112, Issue 6 , Pages 459-462, July 2010